Rheum Flashcards

1
Q

Methotrexate

A

7.5 mg, once a week. can combine with DMARDS, antiinflammatory, slows RA progress, dihydrofolate reductase inhibitor, can give IV via PO (cheaper), reassess at 6-12 weeks, titrate up q 2-4 weeks, follow renal and liver (esp CKD) if Cr>1.5, NEVER use. always use folic acid (1 mg), red liver and pulm toxicity (5%), dec. n/v, check CBC (bone marrow) watch LFT (NO etoh, inc risk). cbc, lft, cr and CXR prior to starting. hep a,b,c, hiv, ppd after starting. cbc lft q 4-8 wks, cr every time you check albumin. no sulfamethazole. male or female, 3 month rule for pregnancy. glucocorticoid start bridge temporarily, helps with pain and inflammation, as low as possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mild RA

A

no TNF inhibitors, use other agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hydrochloroquine

A

DMARD, watch for retinal toxicity, see opthamologist at 6 mo, effective on mild form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

sulfasalazine

A

DMARD, good for mild disease, exp IBD good option, watch bone marrow suppression (CBC), are they tolerating GI issues, effective mostly on mild form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

azathioprine

A

good for IBD, if over 65 and renal insufficiency, good option, can’t use MTX or sulfasalazine, not most effective but effective enough, watch for drug-drug interaction, ALLOPURINOL,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cyclophosphamide

A

used in severe vasculitis, extra-articular involvement, not first line, adjust dose for renal insufficiency, infertility with high doses, greater r/f malignancy, can cause hemorrhagic cystitis, take in am with lots of water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

D-penicilimide

A

for long-term, poorly controlled, bone marrow suppression, rash, nothing tastes good/metallicky, good for persistent symptoms, weight loss, associated with lupus. 125-250 once a day up to 1g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

leflunomide

A

like azothioprine but better, immunosupportive, antiinflammatory, liver function toxicity (rare), low SE profile, long half-life, if wanan get pregnant must wait months and months, take chorostylamine for 2 weeks, decreases hepatic absorption and pregnancy can happen sooner (must be undetectable first)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TNF alpha antagonists

A

Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Certolizumab (Cimzia), Golimumab (Simponi), good drug, good efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Interleukin-1 antagonist

A

Anakintra (Kineret), not very effective, not used often

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Suppress T-Cell activation

A

Abatacept (Orencia), very effective, try if TNF inh doesn’t work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-B-cell monoclonal antibody

A

Rituximab (Rituxan), very effective, try if TNF inh doesn’t work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Infliximab

A

chimeric, 25% mice, the less mice the better outcome, can develop antibodies, essentially a very expensive placebo, must be infused every 4-8 weeks, avoid this. bind and neutralize membranes and circulating tnf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

if tnf-a inh is all human

A

better, no antibodies. can give SQ, easier to give but weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

rituximab

A

b-cell mediated, 3rd or 4th line treatment, causes destruction of b-cells, causes compliment cascade, lots of SE, non-selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

tnf

A

cornerstone of necrosis of the joint, necrosis/ erosion, pain and inflammation, cartiledge damage, dec joint space narrowing

17
Q

ctla4ig-activators

A

abatacept-decrease form of auto-immune disease. t and b cells leave the synovial area alone, 4th or 5th line drug, very exp

18
Q

tozilicumab, IL-6 inhibitor

A

little weak, not used often, mediator of chronic inflammation,

19
Q

Biologics: Relative Contraindications

A
Active Hep B Infection
MS, optic neuritis
Active serious infections
Chronic or recurrent infections
Current neoplasia
History of TB or positive PPD (untreated)
CHF (class III or IV)
20
Q

Safety considerations with biologic DMARDS

A
serious infection
opportunistic inf (TB)
malignancies/lymphoma
demylenination
hematologic abnormalities
admin reactions
CHF
Hepatic
autoantibodies and drug induced lupus
vaccination